top of page
Image by Sean Pollock

Commercial Access

Image by Headway
Image by Dylan Gillis
Image by Jason Goodman
Speak with Us
  • Pharmaceuticals, Therapeutic Products, Orphan Drugs

  • New Chemical Entities, New Drugs, Generic Drugs, Drug Master File 

  • Biologics, Biosimilars, Vaccines, Advanced Drug Therapy, Cell Gene Therapy 

  • Medical Devices and In-vitro Diagnostics

  • Cosmetics 

  • Health Food & Supplements

Commercial Access

Go-to-Market Commercial Growth Consultancy

  • Market size, potential and entry strategy

  • Distributor search, connection and management

  • Product development and launch

  • Pricing and reimbursement

  • Advertisement and promotion review

Image by Scott Graham
Image by Sean Pollock
Image by Christina @ wocintechchat.com

Our Experience

PECAN.Solutions supports companies looking for geographic expansion for their healthcare products ranging from New Chemical Entities (NCE), New Drugs, Generic Drugs, Biologics, Biosimilars, Vaccines, Medical Devices, Cosmetics, Health Food & Supplements etc.

​

Our experts in Go-to-Market & Commercial Growth Consultancy have more than twenty years experience and proven track records in Asia, in the healthcare and life-science industry with combined background from SmithKline Beecham (GSK), Pfizer, J&J, Danone, Merck KGaA, Qiagen, Becton Dickinson, Novartis, UCB, Lundbeck, Eli Lilly etc.

​

They bring with them valuable skillsets in marketing communications, product and commercial launch strategies, distributor search and connection to bring about growth transformation to your business.

How we can help

  • Analyse market size and research opportunities for commercial entry

  • Business development with go-to-market growth implementation strategies

  • Brand positioning strategies

  • Distributor search and channel management

  • Turn around unprofitable businesses and/or tap into new territories

  • Close cross-cultural gaps between East and West to facilitate seamless collaborations

  • Coaching of sales teams for communication effectiveness

  • Promotion and advertisement oversight and risk assessment

  • Reimbursement and Health Technology Assessment

Image by Austin Kehmeier
bottom of page